Edward B. Garon, MD
Medical Oncologist, Oncology & Hematology
David Geffen School of Medicine at UCLA, California
David Geffen School of Medicine at UCLA, California
Authored Items
August 2020 Vol 6 No 4
In this last part of the series, we examine the full patient journey, from diagnosis through treatment, and provide a list of questions for patients to ask their doctors for more information.
Read More ›June 2020 Vol 6 No 3
Non–small-cell lung cancer, or NSCLC, is the most common form of lung cancer, accounting for about 80% to 85% of all lung cancer cases in the United States.
Read More ›April 2020 Vol 6 No 2
In the second article of this 4-part series, the authors present an overview of the current treatment landscape for NSCLC, including a description of the most often used treatments and common questions that patients can ask their providers. Read More ›
February 2020 Vol 6 No 1
Knowing the stage of lung cancer helps oncologists to plan the best treatment plan for each patient. This first article in the series explains how the most common type of lung cancer is staged. Read More ›